June 9 (Reuters) - Probiotec Ltd (PBP) :
- FY21 UNDERLYING EBITDA GUIDANCE $21.0 - $22.0M
- SEES FY211 GUIDANCE RANGE FOR REVENUE $118 – $122M
- EXPECT NSW SITE CONSOLIDATION STRATEGY TO BE MATERIALLY ACCRETIVE FOR SHAREHOLDERS IN MEDIUM TERM
- LATEST LOCKDOWN IN VICTORIA HAS HAD A MINOR NEGATIVE IMPACT ON GROUP’S FY21 EARNINGS
News: PBP Probiotec Ltd Sees FY21 Underlying EBTIDA Of $21 Mln To $22 Mln
Add to My Watchlist
What is My Watchlist?